Why the study?
As cancer-specific mortality decreases and the surviving population ages, there is an increasing need to identify cancer patients at an increased risk of death from heart disease.
Does having cancer increase the risk of fatal heart disease compared to the general population?
Does having cancer increase the risk of fatal heart disease compared to the general population?
Cancer patients have a more than twofold increased risk of fatal heart disease compared to the general population, highlighting the need for targeted cardiovascular risk assessment in this aging and growing population.
Cancer diagnosis was associated with >2-fold higher fatal heart disease mortality; leaves open whether targeted cardio-oncology screening improves survival.
As the overlap between heart disease and cancer patients increases as cancer-specific mortality is decreasing and the surviving population is aging, it is necessary to identify cancer patients who are at an increased risk of death from heart disease. The purpose of this study is to identify cancer patients at highest risk of fatal heart disease compared to the general population and other cancer patients at risk of death during the study time period. Here we report that 394,849 of the 7,529,481 cancer patients studied died of heart disease. The heart disease-specific mortality rate is 10.61/10,000-person years, and the standardized mortality ratio (SMR) of fatal heart disease is 2.24 (95% CI: 2.23-2.25). Compared to other cancer patients, patients who are older, male, African American, and unmarried are at a greatest risk of fatal heart disease. For almost all cancer survivors, the risk of fatal heart disease increases with time.
No takes yet. Share an insight, caveat, or question.
Stoltzfus et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: